Live Breaking News & Updates on Merck V116|Page 1

Stay updated with breaking news from Merck v116. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Merck's V116 Vaccine Shows Promising Results in Phase 3 Studies at ISPPD: Key Findings and Real-World Impact

Merck's V116, a 21-valent pneumococcal vaccine, exhibits strong immunogenicity and coverage in diverse adult populations. Real-world data reveal its potential to combat pneumococcal diseases effectively.
....

South Africa , Cape Town , Western Cape , Heather Platt , Merck Heather Platt , Meeting Of The International Society Pneumonia , Global Clinical Development For Vaccines , Infection Intel , Staying Ahead , Infection Control , International Society , Pneumococcal Diseases , Prescription Drug User Fee Act , Pneumococcal Pneumonia Epidemiology , Urine Serotyping , Mental Outcomes , Global Clinical Development , Merck V116 ,